Market Trends– category –
-
Cellistic CTO Highlights Japanese Conditional Approvals for Cardiac and Parkinson’s iPSC Products, Outlining Path to Commercial-Scale iPSC Cell Therapy Manufacturing
The Medicine Maker UK Overview In an interview with The Medicine Maker, Stefan Braam, CTO of Cellistic, stated that the industry's main focus is the ability to consistently provide iPSC-based cell therapies at commercial scale for large ... -
Ultragenyx’s Genglycos Secures FDA Approval as First Gene Therapy for GSDIa – Bolstering In-House Manufacturing and Long-Term Post-Marketing Monitoring
Pharmaceutical Technology USA Overview Ultragenyx Pharmaceutical has received FDA accelerated approval for Genglycos (pariglasgene brecaparvovec-opnr), the first gene therapy targeting the root cause of the ultra-rare metabolic disorder,... -
Ultragenyx’s Genglycos Receives FDA Accelerated Approval as First Gene Therapy for Glycogen Storage Disease Type Ia, Requiring 10-Year Post-Marketing Monitoring
Pharmaceutical Technology USA Overview Ultragenyx Pharmaceutical announced that Genglycos (pariglasgene brecaparvovec-opnr), the first gene therapy for Glycogen Storage Disease Type Ia (GSDIa), has received FDA accelerated approval. This... -
DelveInsight Report: Over 12 Companies Enter iPSC-Derived NK Cell Therapy Pipeline, Led by Century Therapeutics and Fate Therapeutics
openPR.com (DelveInsight) India Overview This article provides an overview of a market research report published by DelveInsight, highlighting the rapid growth in the iPSC-derived NK cell therapy pipeline, with over 12 companies developi... -
Editas Medicine Stock Soars 14.4% on Q2 Revenue Beat, Investor Focus on Gene-Editing Pipeline Intensifies
MarketBeat USA Overview Editas Medicine reported a Q2 2026 revenue of $11.89 million, significantly surpassing analyst estimates of $2.85 million, alongside an adjusted EPS loss of $0.15, better than the projected $0.27 loss, leading to ... -
Rundoo Secures Total of $48 Million in Financing, Including $30 Million Series B, for AI-First Platform Serving Independent Supply Stores
Business Wire USA Overview Rundoo has secured $48 million in total financing, including a $30 million Series B round, to further develop its AI-first platform for independent supply stores. This platform offers integrated tools like POS,... -
Partners Group Invests Over $1 Billion in UK’s AVK to Power AI Data Centers, Expanding On-site Energy Infrastructure
Digitalisation World UK Overview Partners Group, a global private markets investment manager, has made a substantial investment exceeding $1 billion in AVK, a UK-based power solutions provider. This capital injection aims to support the ... -
Wingspire Equipment Finance Provides $140 Million Financing for High-Performance AI Compute Infrastructure Expansion
Business Wire USA Overview Wingspire Equipment Finance has provided $140 million in equipment financing to a private equity-backed firm delivering GPU cloud computing capabilities to AI labs and enterprises. This funding is dedicated to ... -
Twin1 AI Raises $20 Million Seed Round to Build AI-Powered Digital Twins for Professional Knowledge Workers
Business Wire / Morningstar USA Overview Twin1 AI has successfully raised $20 million in seed funding to develop AI-powered digital twins for professional knowledge workers. This capital will be allocated towards team expansion, market p... -
TrendForce Predicts Liquid Cooling to Dominate AI Infrastructure by 2026, Reaching 53% AI Chip Penetration Driven by Google
ET Datacenters India Overview A TrendForce report indicates that liquid cooling is rapidly becoming the standard for high-end AI infrastructure, with its penetration among AI chips projected to reach 53% by 2026 and nearly 60% by 2027. T...
